Danny Rischin
- Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies 123
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers 59
- CAR-T cell therapy research 31
- Cancer Diagnosis and Treatment 29
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 40
- Lung Cancer Diagnosis and Treatment 28
- Cancer Research top 0.5%
-
- Head and Neck Surgical Oncology 39
-
- Nonmelanoma Skin Cancer Studies 39
- Co-authors
- June CorryLester J. PetersRodney J. HicksRichard FisherBenjamin SolomonRichard J. YoungA. FeyereislovaSandro Porceddu
- Journals
- Journal of Clinical Oncology (88 papers)Annals of Oncology (39 papers)International Journal of Radiation Oncology*Biology*Physics (29 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Danny Rischin
353 papers receiving 15.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Otorhinolaryngology 3.6k
- Oncology 7.8k
- Pulmonary and Respiratory Medicine 6.2k
- Cancer Research 2.2k
- Radiology, Nuclear Medicine and Imaging 2.3k
Countries citing papers authored by Danny Rischin
This map shows the geographic impact of Danny Rischin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Rischin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Rischin more than expected).
Fields of papers citing papers by Danny Rischin
This network shows the impact of papers produced by Danny Rischin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Rischin. The network helps show where Danny Rischin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danny Rischin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2020 | 83 | |
| 7 | 2018 | 100 | |
| 8 | 2018 | 166 | |
| 9 | 2016 | 100 | |
| 10 | 2015 | 59 | |
| 11 | 2013 | 90 | |
| 12 | 2012 | 41 | |
| 13 | 2012 | 195 | |
| 14 | 2011 | 70 | |
| 15 | 2011 | 54 | |
| 16 | Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trialbreakdown → | 2010 | 571 |
| 17 | Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02breakdown → | 2010 | 548 |
| 18 | 2005 | 153 | |
| 19 | Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancerbreakdown → | 2003 | 2392 |
| 20 | 2002 | 47 |
About Danny Rischin
Danny Rischin is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 369 papers that have together received 15.4k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (123 papers), Cancer Immunotherapy and Biomarkers (59 papers), Lung Cancer Treatments and Mutations (40 papers), Head and Neck Surgical Oncology (39 papers), Nonmelanoma Skin Cancer Studies (39 papers), CAR-T cell therapy research (31 papers), Cancer Diagnosis and Treatment (29 papers) and Lung Cancer Diagnosis and Treatment (28 papers). The work is most often cited by research in Otorhinolaryngology (3.6k citations), Oncology (7.8k citations) and Pulmonary and Respiratory Medicine (6.2k citations). Danny Rischin has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include June Corry, Lester J. Peters, Rodney J. Hicks, Richard Fisher, Benjamin Solomon, Richard J. Young, A. Feyereislova, Sandro Porceddu, Steven D. Averbuch and José Baselga. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics, Oral Oncology and Head & Neck.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.